Why Jim Cramer Says Walgreen (WAG) Can Go Higher and Monsanto (MON) Is a

NEW YORK (TheStreet) -- Walgreen  (WAG) and Monsanto  (MON) report earnings this week, and TheStreet's Jim Cramer gives his take on both.

Cramer says Rite Aid's  (RAD) big recent earnings drop should not be a red flag for Walgreen's report because Rite Aid had a transition problem with a particular drug distributor, and he wants to buy Rite Aid very aggressively.

He thinks Walgreen continues to have the favor of Wall Street because it has the ability to do inversion, the great Alliance Boots deal, a great balance sheet and a forward-looking CEO in Gregory Wasson. The stock has run a lot, but Cramer believes it can still go higher.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings team also rates Walgreen as a "buy" with a ratings score of A. TheStreet Ratings Team has this to say about their recommendation:

"We rate WALGREEN CO (WAG) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow."

Cramer also says Monsanto is the stock to play if investors want to be in the genetically-modified space. He says natural/organic is a very small percentage of the food chain, and Monsanto helps feed the world in a cheaper way. He notes Monsanto is the biotech company that allows people to get more out of corn and soy and there is an endless demand for protein and these types of products.

Finally, Cramer says Monsanto has been a buy every time it has been hit, and he doesn't think this time would be any different.

TheStreet Ratings team also rates Monsanto as a "buy" with a ratings score of A. TheStreet Ratings Team has this to say about their recommendation:

"We rate MONSANTO CO (MON) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow."

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

If you liked this article you might like

Dow Drops Over 250 Points to End Six-Session Winning Streak

Dow Drops Over 250 Points to End Six-Session Winning Streak

Walmart Sinks Dow; Albertsons to Fight Off Grocery Struggles With Rite Aid-ICYMI

Walmart Sinks Dow; Albertsons to Fight Off Grocery Struggles With Rite Aid-ICYMI

Rite Aid Pops After Albertsons Plans to Buy Part of Drugstore Chain

Rite Aid Pops After Albertsons Plans to Buy Part of Drugstore Chain

Inside Albertsons' Humble Beginnings: Video

Inside Albertsons' Humble Beginnings: Video

Blame Amazon for Walmart's Surprising 2018 Outlook

Blame Amazon for Walmart's Surprising 2018 Outlook